These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
707 related items for PubMed ID: 27338764
1. New York Heart Association functional class, QRS duration, and survival in heart failure with reduced ejection fraction: implications for cardiac resychronization therapy. Braunschweig F, Linde C, Benson L, Ståhlberg M, Dahlström U, Lund LH. Eur J Heart Fail; 2017 Mar; 19(3):366-376. PubMed ID: 27338764 [Abstract] [Full Text] [Related]
2. Gender, underutilization of cardiac resynchronization therapy, and prognostic impact of QRS prolongation and left bundle branch block in heart failure. Linde C, Ståhlberg M, Benson L, Braunschweig F, Edner M, Dahlström U, Alehagen U, Lund LH. Europace; 2015 Mar; 17(3):424-31. PubMed ID: 25164429 [Abstract] [Full Text] [Related]
3. Cardiac resynchronization therapy in women versus men: observational comparative effectiveness study from the National Cardiovascular Data Registry. Zusterzeel R, Spatz ES, Curtis JP, Sanders WE, Selzman KA, Piña IL, Bao H, Ponirakis A, Varosy PD, Masoudi FA, Caños DA, Strauss DG. Circ Cardiovasc Qual Outcomes; 2015 Mar; 8(2 Suppl 1):S4-11. PubMed ID: 25714821 [Abstract] [Full Text] [Related]
4. Age, prognostic impact of QRS prolongation and left bundle branch block, and utilization of cardiac resynchronization therapy: findings from 14,713 patients in the Swedish Heart Failure Registry. Lund LH, Benson L, Ståhlberg M, Braunschweig F, Edner M, Dahlström U, Linde C. Eur J Heart Fail; 2014 Oct; 16(10):1073-81. PubMed ID: 25201219 [Abstract] [Full Text] [Related]
5. Clinical outcomes according to QRS duration and morphology in the irbesartan in patients with heart failure and preserved systolic function (I-PRESERVE) trial. Cannon JA, Shen L, Jhund PS, Anand IS, Komajda M, McKelvie RS, Zile MR, Carson PE, McMurray JJ. Eur J Heart Fail; 2016 Aug; 18(8):1021-31. PubMed ID: 27194023 [Abstract] [Full Text] [Related]
6. QRS axis and the benefit of cardiac resynchronization therapy in patients with mildly symptomatic heart failure enrolled in MADIT-CRT. Brenyo A, Rao M, Barsheshet A, Cannom D, Quesada A, McNitt S, Huang DT, Moss AJ, Zareba W. J Cardiovasc Electrophysiol; 2013 Apr; 24(4):442-8. PubMed ID: 23252875 [Abstract] [Full Text] [Related]
8. Cardiac resynchronization therapy in women: US Food and Drug Administration meta-analysis of patient-level data. Zusterzeel R, Selzman KA, Sanders WE, Caños DA, O'Callaghan KM, Carpenter JL, Piña IL, Strauss DG. JAMA Intern Med; 2014 Aug; 174(8):1340-8. PubMed ID: 25090172 [Abstract] [Full Text] [Related]
9. Sex Differences in Long-Term Outcomes With Cardiac Resynchronization Therapy in Mild Heart Failure Patients With Left Bundle Branch Block. Biton Y, Zareba W, Goldenberg I, Klein H, McNitt S, Polonsky B, Moss AJ, Kutyifa V, MADIT‐CRT Executive Committee. J Am Heart Assoc; 2015 Jun 29; 4(7):. PubMed ID: 26124205 [Abstract] [Full Text] [Related]
10. Cardiac resynchronization therapy in patients with heart failure and moderately reduced ejection fraction: Could it trigger a super-response? Tawfik Ghanem M, Allam LE, Samir Ahmed R. Indian Heart J; 2019 Jun 29; 71(3):229-234. PubMed ID: 31543195 [Abstract] [Full Text] [Related]
11. Impact of QRS complex duration and morphology on left ventricular reverse remodelling and left ventricular function improvement after cardiac resynchronization therapy. van der Bijl P, Khidir M, Leung M, Mertens B, Ajmone Marsan N, Delgado V, Bax JJ. Eur J Heart Fail; 2017 Sep 29; 19(9):1145-1151. PubMed ID: 28176418 [Abstract] [Full Text] [Related]
12. Predicting response to cardiac resynchronization therapy: Use of strict left bundle branch block criteria. Hadjis A, AlTurki A, Proietti R, Montemezzo M, Bernier M, Joza J, Hadjis T, Essebag V. Pacing Clin Electrophysiol; 2019 Apr 29; 42(4):431-438. PubMed ID: 30779177 [Abstract] [Full Text] [Related]
17. True complete left bundle branch block morphology strongly predicts good response to cardiac resynchronization therapy. Tian Y, Zhang P, Li X, Gao Y, Zhu T, Wang L, Li D, Wang J, Yuan C, Guo J. Europace; 2013 Oct 02; 15(10):1499-506. PubMed ID: 23468351 [Abstract] [Full Text] [Related]